HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NBTY Pegs Sports Nutrition To Help Offset Private Label Slump

This article was originally published in The Tan Sheet

Executive Summary

NBTY prioritizes development of sports nutrition products and wants to broaden the category as it increases its focus on branded sales due to competitive pressure in the private label space.

You may also be interested in...

Groups Defend Supplement Safety After Study Shows Higher Mortality Risk

Supplement industry trade groups argue a study that questions the long-term safety of supplements makes unwarranted recommendations.

NBTY Appoints GE Vet To Succeed CEO Rudolph

Newly private NBTY replaces long-time CEO Scott Rudolph with Jeffrey Nagel, a company outsider and supplement industry newcomer.

NBTY Cites Lower Margins As The Cost Of Higher Private-Label Sales

Dietary supplement manufacturer NBTY's gross margins are unlikely to exceed 50 percent again largely because private-label product sales have nearly doubled since its acquisition of Leiner Health Products


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts